- Home
- STCN vs SER Comparison
STCN vs SER Comparison
Compare STCN & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STCN
- SER
- Stock Information
- Founded
- STCN 1986
- SER 2017
- Country
- STCN United States
- SER United States
- Employees
- STCN N/A
- SER N/A
- Industry
- STCN Advertising
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- STCN Consumer Discretionary
- SER Health Care
- Exchange
- STCN Nasdaq
- SER Nasdaq
- Market Cap
- STCN 63.4M
- SER 54.3M
- IPO Year
- STCN 1994
- SER 2018
- Fundamental
- Price
- STCN $9.80
- SER $5.17
- Analyst Decision
- STCN
- SER
- Analyst Count
- STCN 0
- SER 0
- Target Price
- STCN N/A
- SER N/A
- AVG Volume (30 Days)
- STCN 30.8K
- SER 17.4K
- Earning Date
- STCN 12-12-2024
- SER 11-12-2024
- Dividend Yield
- STCN N/A
- SER N/A
- EPS Growth
- STCN 203.29
- SER N/A
- EPS
- STCN 3.11
- SER N/A
- Revenue
- STCN $174,109,000.00
- SER $3,156,637.00
- Revenue This Year
- STCN N/A
- SER N/A
- Revenue Next Year
- STCN N/A
- SER N/A
- P/E Ratio
- STCN $3.27
- SER N/A
- Revenue Growth
- STCN N/A
- SER 2436.14
- 52 Week Low
- STCN $7.36
- SER $3.81
- 52 Week High
- STCN $13.00
- SER $23.18
- Technical
- Relative Strength Index (RSI)
- STCN 40.83
- SER 37.60
- Support Level
- STCN $9.66
- SER $5.00
- Resistance Level
- STCN $10.32
- SER $5.76
- Average True Range (ATR)
- STCN 0.61
- SER 0.77
- MACD
- STCN -0.02
- SER -0.14
- Stochastic Oscillator
- STCN 8.81
- SER 34.39
About STCN Steel Connect Inc.
Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.